The new score predicts 1-year poor outcome in patients with successful percutaneous coronary intervention: Naples prognostic score

Alkame Akgümüş; Ahmet Balun

Article Details

The new score predicts 1-year poor outcome in patients with successful percutaneous coronary intervention: Naples prognostic score

Authors:

Alkame Akgümüş | Ahmet Balun

Publisher:

MediHealth Academy Yayıncılık

Main Topics:

Kardiyoloji

Journal:

Anatolian Current Medical Journal Vol.5 Issue 4, pp.416-420

Document Type:

Article

Publication Date:

10/2023

Document Language:

English

Document ID (Org No.):

2001302545

pISSN:

2718-0115

Keywords:

Abstract:

 Aims: This study investigated the relationship between Naples prognostic score NPS and 1-year poor clinical outcomes in patients presenting with non-ST-segment elevation myocardial infarction NSTEMI. Methods: The study included 121 patients who had NSTEMI and received successful PCI treatment. The researchers calculated NPS using the neutrophillymphocyte ratio, lymphocytemonocyte ratio, serum albumin level, and total cholesterol. The patients were divided into two groups based on their NPS scores: those with scores of 0.1 and 2 and those with scores of 3 and 4. The study compared the occurrence of major cardiovascular events MACE such as 1-year all-cause mortality, 1-year nonfatal recurrent MI, and stroke between the two groups. Results: Patients with high NPS scores were observed to have significantly higher all-cause mortality than those with low NPS scores 23.9 vs. 9.3, p0.029. When the MACEs of the patients were compared, significantly higher MACE was observed in the high NPS group 39.1 vs. 18.7, p0.013. In multivariate logistic regression analysis, creatinine OR:4,914, CI 95: 1.310-18,433, p0.018 and NPS 3-4 OR:2.565, CI 95: 1.093-6.017, p0.030 were independent predictors of MACE. Conclusion: Composite MACEs of non-fatal recurrent MI, cerebrovascular accident, and all-cause death were higher at one year in patients with high NPS who underwent successful percutaneous intervention. High NPS is an indicator of MACE.

 Aims: This study investigated the relationship between Naples prognostic score NPS and 1-year poor clinical outcomes in patients presenting with non-ST-segment elevation myocardial infarction NSTEMI. Methods: The study included 121 patients who had NSTEMI and received successful PCI treatment. The researchers calculated NPS using the neutrophillymphocyte ratio, lymphocytemonocyte ratio, serum albumin level, and total cholesterol. The patients were divided into two groups based on their NPS scores: those with scores of 0.1 and 2 and those with scores of 3 and 4. The study compared the occurrence of major cardiovascular events MACE such as 1-year all-cause mortality, 1-year nonfatal recurrent MI, and stroke between the two groups. Results: Patients with high NPS scores were observed to have significantly higher all-cause mortality than those with low NPS scores 23.9 vs. 9.3, p0.029. When the MACEs of the patients were compared, significantly higher MACE was observed in the high NPS group 39.1 vs. 18.7, p0.013. In multivariate logistic regression analysis, creatinine OR:4,914, CI 95: 1.310-18,433, p0.018 and NPS 3-4 OR:2.565, CI 95: 1.093-6.017, p0.030 were independent predictors of MACE. Conclusion: Composite MACEs of non-fatal recurrent MI, cerebrovascular accident, and all-cause death were higher at one year in patients with high NPS who underwent successful percutaneous intervention. High NPS is an indicator of MACE.

 Aims: This study investigated the relationship between Naples prognostic score NPS and 1-year poor clinical outcomes in patients presenting with non-ST-segment elevation myocardial infarction NSTEMI. Methods: The study included 121 patients who had NSTEMI and received successful PCI treatment. The researchers calculated NPS using the neutrophillymphocyte ratio, lymphocytemonocyte ratio, serum albumin level, and total cholesterol. The patients were divided into two groups based on their NPS scores: those with scores of 0.1 and 2 and those with scores of 3 and 4. The study compared the occurrence of major cardiovascular events MACE such as 1-year all-cause mortality, 1-year nonfatal recurrent MI, and stroke between the two groups. Results: Patients with high NPS scores were observed to have significantly higher all-cause mortality than those with low NPS scores 23.9 vs. 9.3, p0.029. When the MACEs of the patients were compared, significantly higher MACE was observed in the high NPS group 39.1 vs. 18.7, p0.013. In multivariate logistic regression analysis, creatinine OR:4,914, CI 95: 1.310-18,433, p0.018 and NPS 3-4 OR:2.565, CI 95: 1.093-6.017, p0.030 were independent predictors of MACE. Conclusion: Composite MACEs of non-fatal recurrent MI, cerebrovascular accident, and all-cause death were higher at one year in patients with high NPS who underwent successful percutaneous intervention. High NPS is an indicator of MACE.

 Aims: This study investigated the relationship between Naples prognostic score NPS and 1-year poor clinical outcomes in patients presenting with non-ST-segment elevation myocardial infarction NSTEMI. Methods: The study included 121 patients who had NSTEMI and received successful PCI treatment. The researchers calculated NPS using the neutrophillymphocyte ratio, lymphocytemonocyte ratio, serum albumin level, and total cholesterol. The patients were divided into two groups based on their NPS scores: those with scores of 0.1 and 2 and those with scores of 3 and 4. The study compared the occurrence of major cardiovascular events MACE such as 1-year all-cause mortality, 1-year nonfatal recurrent MI, and stroke between the two groups. Results: Patients with high NPS scores were observed to have significantly higher all-cause mortality than those with low NPS scores 23.9 vs. 9.3, p0.029. When the MACEs of the patients were compared, significantly higher MACE was observed in the high NPS group 39.1 vs. 18.7, p0.013. In multivariate logistic regression analysis, creatinine OR:4,914, CI 95: 1.310-18,433, p0.018 and NPS 3-4 OR:2.565, CI 95: 1.093-6.017, p0.030 were independent predictors of MACE. Conclusion: Composite MACEs of non-fatal recurrent MI, cerebrovascular accident, and all-cause death were higher at one year in patients with high NPS who underwent successful percutaneous intervention. High NPS is an indicator of MACE.

Article Details

The new score predicts 1-year poor outcome in patients with successful percutaneous coronary intervention: Naples prognostic score

Authors:

Alkame Akgümüş | Ahmet Balun

Publisher:

MediHealth Academy Yayıncılık

Main Topics:

Kardiyoloji

Journal:

Anatolian Current Medical Journal Vol.5 Issue 4, pp.416-420

Document Type:

Article

Publication Date:

10/2023

Document Language:

English

Document ID (Org No.):

2001302545

pISSN:

2718-0115

Naples prognostic score

Acute coronary syndrome

Mortality

Issues

Article Details

The new score predicts 1-year poor outcome in patients with successful percutaneous coronary intervention: Naples prognostic score

Authors: Alkame Akgümüş | Ahmet Balun

Publisher: MediHealth Academy Yayıncılık

Main Topics: Kardiyoloji

Journal: Anatolian Current Medical Journal Vol.5 Issue 4, pp.416-420

Document Type: Article

Publication Date: 10/2023

Document Language: English

Document ID (Org No.): 2001302545

pISSN: 2718-0115

Naples prognostic score

Acute coronary syndrome

Mortality

Issues

Authors:

Alkame Akgümüş | Ahmet Balun

Publisher:

MediHealth Academy Yayıncılık

Main Topics:

Kardiyoloji

Journal:

Anatolian Current Medical Journal Vol.5 Issue 4, pp.416-420

Document Type:

Article

Publication Date:

10/2023

Document Language:

English

Document ID (Org No.):

2001302545

pISSN:

2718-0115